35 results
Posted on 06.04.2011
On e-health and medical technology: grasp the nettle or pay a high price?
Chairing a two day conference on e-health and presenting at a groundbreaking Innovation in Healthcare conference put on by DG Research has further fuelled my enthusiasm for telling the story about the power of technology to enable massive changes to the way that populations are cared for, whilst simultaneously improving outcomes, the patient experience and cost. If all this seems too good to be true just look at what the alternatives might be.
Posted on 01.04.2011
UDI, GS1, GTIN, GHTF, ETF, EHR, ISMP… What does it mean to me and to you?
Having been involved with the medical devices industry for many years, I’ve seen how the industry has evolved using innovative solutions and has constantly embraced technological developments. Recently however I had a friend on the receiving end of this technology and I hope you find his ‘patient case report’ below of interest – do note he also works in the medtech industry hence his knowledge on this subject…
Can we move global harmonisation to the next level?
Proponents of greater regulatory harmonisation and cooperation will have been heartened by FDA chief Peggy Hamburg’s comments at the Advamed 2010 conference on Wednesday 20 October. She was quick to acknowledge that, in a changing world with vastly increased trade, the FDA could not continue to operate on an old-fashioned model designed for a time […]
Posted on 01.10.2010
Adam Smith, corruption and biases
The 7th European Healthcare Fraud & Corruption Network conference took place in Brussels at the end of September and featured high level speakers and experts. The event proved to be an ideal platform for discussing a number of topics of relevance to all the stakeholders in the healthcare system. The “Conflicts of Interest” session was […]
Posted on 23.09.2010
More EU needed to ride the Chinese wave
The occasion of the annual visit of the European Chamber of Commerce in Europe afforded me the rare opportunity to meet both a group of senior industry leaders from China and the Chinese ambassador to the EU, and his trade officials. What was clear from this excellent opportunity to gain first hand insights on the […]
Musings on markets from weary traveller
Like much of the business community I have had plenty of time for thought and reading. A 24 hour trip to Milan has turned into a five day marathon. Both reading and experience have stimulated thoughts about the operation of markets. Firstly, after several hours on Thursday, I managed to secure a hotel room in […]
Posted on 11.03.2010
Today is World Kidney Day
The prominence of World Kidney Day (11th March) brings into sharp focus the changing epidemiology of our times and the impact of modern life styles of the developed world on the demands placed on healthcare systems. The surge in incidence of diabetes coupled with extending life expectancy are producing a parallel rise in the incidence […]
Outsourcing R&D and the Medtech industry
In recent weeks within the pharmaceutical industry there has been much talk of both downsizing – GSK and AstraZeneca shedding 11,000 jobs – and outsourcing of research and development, with a whole range of licensing or partnership deals designed to pad out faltering product pipelines. Once again I was prompted to think about the prospect […]